Pilot study of recombinant human granulocyte‐macrophage colony–stimulating factor in the treatment of chronic hepatitis B
Julio Martin, Orencio Bosch, Gloria Moraleda, Javier Bartolome, Juan Antonio Quiroga, Vicente Carreño – 1 October 1993 – Recombinant human granulocyte‐macrophage colony‐stimulating factor is being used to improve the immunological function of patients with various diseases and to ameliorate hematological disorders.